J Korean Diabetes.  2014 Dec;15(4):211-215. 10.4093/jkd.2014.15.4.211.

Heart Rate Variability and the Risk of Cardiovascular Disease

• Kim TH
• Kim JY

• KMID: 2173866
• DOI: http://doi.org/10.4093/jkd.2014.15.4.211

Abstract

The analysis of heart rate variability (HRV) has recently been established as a non-invasive measurement method for estimation of autonomic nervous system function in the cardiovascular system. HRV reflects the interaction of the sympathetic and parasympathetic nervous systems and the regulation of the cardiovascular system by the autonomic nervous system, and various measures of HRV, such as time-domain, frequency domain, and non-linear measures of HR variability, have been used in risk stratification of cardiovascular disease. Many studies have demonstrated that patients with reduced HRV have an increased risk of mortality after an acute myocardial infarction (AMI) or after a diagnosis of heart failure. HRV performed late after AMI (> 6 wks) better predicts sudden cardiac death and fatal arrhythmia than does HRV at the early phase after AMI, suggesting that impaired recovery of the autonomic nervous system and remodeling of the arrhythmia substrate after AMI may play critical roles in the mechanism of sudden cardiac death. Therefore, early measurement of HRV to identify high risk patients might be repeated later in order to investigate and follow the risk of sudden cardiac death. Future randomized trials using HRV as one of the inclusion criteria should determine whether routine measurement of HR variability can be a useful routine clinical tool for risk stratification in cardiovascular disease.

Keyword

Heart rate; Cardiovascular diseases; Myocardial infarction; Autonomic nervous system

MeSH Terms

Arrhythmias, Cardiac
Autonomic Nervous System
Cardiovascular Diseases*
Cardiovascular System
Death, Sudden, Cardiac
Diagnosis
Heart Failure
Heart Rate*
Humans
Mortality
Myocardial Infarction
Parasympathetic Nervous System

Reference

References

1. Wolf MM, Varigos GA, Hunt D, Sloman JG. Sinus arrhythmia in acute myocardial infarction. Med J Aust. 1978; 2:52–3.

2. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987; 59:256–62.

3. Bigger JT Jr, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992; 85:164–71.

4. Malik M, Farrell T, Cripps T, Camm AJ. Heart rate variability in relation to prognosis after myocardial infarction: selection of optimal processing techniques. Eur Heart J. 1989; 10:1060–74.

5. Fei L, Copie X, Malik M, Camm AJ. Short- and longterm assessment of heart rate variability for risk stratification after acute myocardial infarction. Am J Cardiol. 1996; 77:681–4.

6. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998; 351:478–84.

7. Erdogan A, Coch M, Bilgin M, Parahuleva M, Tillmanns H, Waldecker B, Soydan N. Prognostic value of heart rate variability after acute myocardial infarction in the era of immediate reperfusion. Herzschrittmacherther Elektrophysiol. 2008; 19:161–8.

8. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol. 1993; 21:729–36.

9. Janszky I, Ericson M, Mittleman MA, Wamala S, Al-Khalili F, Schenck-Gustafsson K, Orth-Gomer K. Heart rate variability in longterm risk assessment in middle-aged women with coronary heart disease: The Stockholm Female Coronary Risk Study. J Intern Med. 2004; 255:13–21.

10. Jokinen V, Tapanainen JM, Seppänen T, Huikuri HV. Temporal changes and prognostic significance of measures of heart rate dynamics after acute myocardial infarction in the beta-blocking era. Am J Cardiol. 2003; 92:907–12.

11. Mäkikallio TH, Tapanainen JM, Tulppo MP, Huikuri HV. Clinical applicability of heart rate variability analysis by methods based on nonlinear dynamics. Card Electrophysiol Rev. 2002; 6:250–5.

12. Huikuri HV, Mäkikallio TH, Peng CK, Goldberger AL, Hintze U, M⊘ller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation. 2000; 101:47–53.

13. Hohnloser SH, Kuck KH, Dorian P, Roberts RS, Hampton JR, Hatala R, Fain E, Gent M, Connolly SJ. DINAMIT Investigators. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med. 2004; 351:2481–8.

14. Huikuri HV, Raatikainen MJ, Moerch-Joergensen R, Hartikainen J, Virtanen V, Boland J, Anttonen O, Hoest N, Boersma LV, Platou ES, Messier MD, Bloch-Thomsen PE. Cardiac Arrhythmias and Risk Stratification after Acute Myocardial Infarction study group. Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction. Eur Heart J. 2009; 30:689–98.

15. Nolan J, Batin PD, Andrews R, Lindsay SJ, Brooksby P, Mullen M, Baig W, Flapan AD, Cowley A, Prescott RJ, Neilson JM, Fox KA. Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation. 1998; 98:1510–6.

16. Rashba EJ, Estes NA, Wang P, Schaechter A, Howard A, Zareba W, Couderc JP, Perkiomaki J, Levine J, Kadish A. Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: results from the DEFINITE trial. Heart Rhythm. 2006; 3:281–6.

17. Piotrowicz E, Baranowski R, Piotrowska M, Zieliński T, Piotrowicz R. Variable effects of physical training of heart rate variability, heart rate recovery, and heart rate turbulence in chronic heart failure. Pacing Clin Electrophysiol. 2009; 32(Suppl 1):S113–5.

18. Liao D, Cai J, Brancati FL, Folsom A, Barnes RW, Tyroler HA, Heiss G. Association of vagal tone with serum insulin, glucose, and diabetes mellitus −the ARIC Study. Diabetes Res Clin Pract. 1995; 30:211–21.

19. Singh JP, Larson MG, O'Donnell CJ, Wilson PF, Tsuji H, Lloyd-Jones DM, Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol. 2000; 86:309–12.

20. Carnethon MR, Golden SH, Folsom AR, Haskell W, Liao D. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk In Communities study, 1987–1998. Circulation. 2003; 107:2190–5.

21. Carnethon MR, Prineas RJ, Temprosa M, Zhang ZM, Uwaifo G, Molitch ME. Diabetes Prevention Program Research Group. The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. Diabetes Care. 2006; 29:914–9.

22. Assoumou HG, Pichot V, Barthelemy JC, Dauphinot V, Celle S, Gosse P, Kossovsky M, Gaspoz JM, Roche F. Metabolic syndrome and short-term and longterm heart rate variability in elderly free of clinical cardiovascular disease: the PROOF study. Rejuvenation Res. 2010; 13:653–63.

23. Brunner EJ, Hemingway H, Walker BR, Page M, Clarke P, Juneja M, Shipley MJ, Kumari M, Andrew R, Seckl JR, Papadopoulos A, Checkley S, Rumley A, Lowe GD, Stansfeld SA, Marmot MG. Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study. Circulation. 2002; 106:2659–65.

24. Stuckey MI, Tulppo MP, Kiviniemi AM, Petrella RJ. Heart rate variability and the metabolic syndrome: a systematic review of the literature. Diabetes Metab Res Rev. 2014; 30:784–93.